Epidemiological approach to the control of horse strongyles.
An investigation of the spring rise in strongyle egg output of grazing horses on two commercial horse farms in northern USA in 1981 and 1982 revealed two distinct spring and summer rises in faecal egg counts, with peaks in May and August/September. There was a marked rise in the concentration of infective larvae on pasture two to four weeks after the peaks in egg output, so that grazing horses were at serious risk from June onwards and pasture larval counts on one farm did not fall to low levels until June of the following year. The spring and summer rises in faecal egg counts appeared to be seasonal in nature, to be derived largely from worms developing from previously ingested larvae, rather than from newly ingested larvae, and to be unrelated to the date of foaling. An epidemiological approach to strongyle control based on prophylactic treatments in the spring successfully eliminated the spring rise in egg output but was inadequate to control the summer rise or subsequent escalation of pasture infectivity in September. It was, nevertheless, superior to a conventional treatment programme at eight week intervals, using the same drug, pyrantel pamoate. Prophylactic spring/summer treatments proved to be much more effective. Both pyrantel pamoate at four week intervals and ivermectin at eight week intervals kept faecal egg counts at low levels during spring and summer. As few as two ivermectin treatments (11 May, 6 July) resulted in a sixfold reduction in pasture larval counts on 9 November and 3 January for the treated group (8872, 8416 stage three larvae [L3]/kg) compared to the control group (52,824, 50,984 L3/kg).(ABSTRACT TRUNCATED AT 250 WORDS)
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D005243:Feces / Q000469:parasitology; D006736:Horses; D007559:Ivermectin; D007783:Lactones / Q000627:therapeutic use*; D007814:Larva; D010270:Parasite Egg Count / Q000662:veterinary; D011715:Pyrantel / Q000031:analogs & derivatives*; D011716:Pyrantel Pamoate / Q000627:therapeutic use*; D013319:Strongyle Infections, Equine / Q000188:drug therapy / Q000453:epidemiology* / Q000469:parasitology
D000871:Anthelmintics; D007783:Lactones; D011715:Pyrantel; D007559:Ivermectin; D011716:Pyrantel Pamoate